Last update:

Clinical pharmacology news

Experimental drug alleviates symptoms of Huntington's disease

The hereditary disorder Huntington's disease has so far been considered incurable. Its clinical manifestations include impaired motor control and psychiatric symptoms. A new study offers promising insights. It shows that ...

Cancer cell 'degraders' target two proteins at once to defeat treatment resistance

Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.

Three-in-one vaccine shows promise against 'tripledemic'

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs ...

Will GLP-1s lead to fewer prescriptions for older adults?

As people age, they often develop chronic conditions, many of which need to be managed with multiple prescription medications. While medications are important for disease management, polypharmacy poses an increased risk for ...

Using AI to tackle global superbug crisis

The development of new antibiotics could be sped up thanks to a new tool that tests the reliability of AI. University of Queensland researchers designed a framework to address the global threat of antimicrobial resistance, ...

New oral GLP-1 drug delivers up to 12% weight loss in 36 weeks

A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to a 12% reduction in body weight after 36 weeks, according to a randomized phase II clinical trial published in Nature ...